21 results
10-K
2022 FY
OBSVF
ObsEva SA
31 Mar 23
Annual report
4:01pm
That Prevent Inspections
Not applicable.
Table of Contents
PART III
Item 10. Directors, Executive Officers and Corporate Governance
Directors
Our … and Corporate Governance Committee
(3) Dr. Loumaye served as our Chief Executive Officer until December 1, 2020, and was appointed as Interim Chair
6-K
OBSVF
ObsEva SA
1 Dec 22
Index to Unaudited Condensed Consolidated Financial Statements
4:15pm
time and cost. We may also be required to make changes in our corporate governance practices in accordance with various SEC and Nasdaq listing rules
6-K
OBSVF
ObsEva SA
17 Aug 22
Index to Unaudited Condensed Consolidated Financial Statements
4:01pm
corporate governance practices in accordance with various SEC and Nasdaq listing rules. The regulatory and compliance costs to us under U.S. securities laws
6-K
EX-99.1
OBSVF
ObsEva SA
7 Apr 22
ObsEva Annual General Meeting 2022
7:01am
chaired and governed inter-company collaborations, and has chaired, co-chaired and served on multiple executive US and global governance committees
6-K
EX-99.2
v1lg wg6xcd9
22 Nov 21
Obseva Announces U.S. FDA Acceptance of New Drug Application for Linzagolix
6:05am
6-K
6nybvqn7d fw
1 Jun 21
ObsEva SA Announces that Shareholders Approved all Board Proposals at its
6:30am
6-K
EX-99.1
af70 4arrk6qigmofq8
25 May 21
ObsEva Announces Proposed Changes to the Composition of its
5:22pm
6-K
EX-99.1
yot9ph66dp1lkn532myr
22 Apr 21
ObsEva Annual General Meeting 2021
6:31am
6-K
EX-99.1
harme mo4sm18
7 Aug 19
Current report (foreign)
7:21am
20-F
1rexf8
21 Apr 17
Annual report (foreign)
12:00am
F-1
w67d321zyw mh
30 Dec 16
Registration statement (foreign)
12:00am
F-1
EX-4.2
fwe1o9d qe6xa
30 Dec 16
Registration statement (foreign)
12:00am
DRS
qo87mdce
14 Oct 16
Draft registration statement
12:00am